Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor

Publisher： Karger

E-ISSN： 1660-3818|43|6|433-435

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.43, Iss.6, 2016-10, pp. : 433-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of hematopoietic stem cell yield after mobilization with granulocyte–colony‐stimulating factor in healthy unrelated donors

By  

TRANSFUSION, Vol. 55, Iss. 12, 2015-12 ,pp. : 2855-2863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclophosphamide plus granulocyte‐colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 31, Iss. 5, 2016-10 ,pp. : 423-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Stem Cell Factor and Granulocyte-Colony Stimulating Factor in Treatment of Stroke

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 1, 2013-04 ,pp. : 2-12

Bentham Science Publishers

Access to resources Recommend Favorite

Biosimilar granulocyte–colony‐stimulating factor for healthy donor stem cell mobilization: need we be afraid?

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 430-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison between biosimilar filgrastim vs other granulocyte‐colony stimulating factor formulations (originator filgrastim, peg‐filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 2, 2015-04 ,pp. : 293-296

John Wiley & Sons Inc

Access to resources Recommend Favorite